Skip to main content
Premium Trial:

Request an Annual Quote

Vin Miles, Kelli Richard

Premium
Abingworth, a life sciences investment group, recently announced the appointment of Vin Miles as venture partner.
 
Miles, the former senior vice president of business development at Alnylam Pharmaceuticals, will be responsible for evaluating new investment opportunities and supporting portfolio companies on the East coast, Abingworth said.
 

 
Invitrogen has appointed Kelli Richard vice president of finance and chief accounting officer.
 
Before joining Invitrogen in 2005, Richard spent 14 years in accounting and financial reporting, and was vice president of accounting and reporting and a principal accounting officer at Gateway.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.